KOCH KEVIN

Insider CIK 1185829 · ARRY President, CSO, Director · MGEN Director · EWTX President and CEO, Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2026-08-12	2026-08-14	17,969	—	$0	35,938	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2026-08-12	2026-08-14	21,875	—	$0	65,625	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	100,000	—	$0	100,000	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	200,000	—	$0	200,000	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2026-08-12	2026-08-14	913	$44.33	$40.5K	52,488	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2026-08-12	2026-08-14	17,969	—	$0	48,584	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2026-08-12	2026-08-14	21,875	—	$0	70,459	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2026-08-12	2026-08-14	8,782	$43.64	$383.2K	61,677	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2026-08-12	2026-08-14	8,276	$43.66	$361.3K	53,401	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	200,000	—	$0	200,000	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	100,000	—	$0	100,000	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2026-08-12	2026-08-14	21,875	—	$0	65,625	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2026-08-12	2026-08-14	17,969	—	$0	35,938	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2026-08-12	2026-08-14	913	$44.33	$40.5K	52,488	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2026-08-12	2026-08-14	8,276	$43.66	$361.3K	53,401	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2026-08-12	2026-08-14	8,782	$43.64	$383.3K	61,677	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2026-08-12	2026-08-14	21,875	—	$0	70,459	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2026-08-12	2026-08-14	17,969	—	$0	48,584	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2025-08-12	2025-08-14	17,968	—	$0	53,907	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2025-08-12	2025-08-14	87,500	—	$0	87,500	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2025-08-12	2025-08-14	525,000	—	$0	525,000	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2025-08-12	2025-08-14	17,968	—	$0	38,587	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2025-08-12	2025-08-14	7,972	$13.39	$106.7K	30,615	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2025-05-02	2025-05-07	4,276	$16.45	$70.3K	20,619	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2025-05-01	2025-05-07	10,417	—	$0	0	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2025-05-01	2025-05-07	10,417	—	$0	24,895	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2025-03-07	2025-03-11	100	—	$0	41,545	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2025-03-07	2025-03-11	100	$0.18	$18	14,578	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2025-03-07	2025-03-11	100	$30.00	$3.0K	14,478	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2025-02-06	2025-02-07	900	—	$0	41,645	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2025-02-06	2025-02-07	900	$13.11	$11.8K	15,378	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2025-02-06	2025-02-07	900	$31.13	$28.0K	14,478	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2025-02-05	2025-02-07	8,636	—	$0	42,545	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2025-02-05	2025-02-07	8,636	$30.03	$259.3K	14,478	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2025-02-05	2025-02-07	8,636	$0.18	$1.6K	23,114	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2024-08-12	2024-08-14	71,875	—	$0	71,875	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2024-08-12	2024-08-14	431,250	—	$0	431,250	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2024-05-02	2024-05-03	3,152	$18.91	$59.6K	14,478	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2024-05-01	2024-05-03	10,417	—	$0	10,417	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2024-05-01	2024-05-03	10,417	—	$0	17,630	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2023-08-17	2023-08-18	600,000	—	$0	600,000	SEC↗
EWTX Edgewise Therapeutics, Inc	S Sale	2023-05-02	2023-05-03	3,203	$8.90	$28.5K	7,213	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise deriv	2023-05-01	2023-05-03	10,416	—	$0	20,834	SEC↗
EWTX Edgewise Therapeutics, Inc	M Exercise	2023-05-01	2023-05-03	10,416	—	$0	10,416	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2022-08-08	2022-08-10	550,000	—	$0	550,000	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2022-05-01	2022-05-03	31,250	—	$0	31,250	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2021-08-17	2021-08-19	400,000	—	$0	400,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2020-05-21	2020-05-22	24,000	—	$0	24,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2019-06-19	2019-06-21	12,000	—	$0	12,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2018-06-27	2018-06-28	12,000	—	$0	12,000	SEC↗
MGEN MIRAGEN THERAPEUTICS, INC.	A Award deriv	2017-06-28	2017-06-30	12,000	—	$0	12,000	SEC↗
ARRY ARRAY BIOPHARMA INC	M Exercise deriv	2013-07-24	2013-07-25	22,286	—	$0	0	SEC↗
ARRY ARRAY BIOPHARMA INC	F Tax w/h	2013-07-24	2013-07-25	12,365	$6.07	$75.1K	784,875	SEC↗
ARRY ARRAY BIOPHARMA INC	M Exercise	2013-07-24	2013-07-25	22,286	$3.75	$83.6K	797,240	SEC↗
ARRY ARRAY BIOPHARMA INC	F Tax w/h	2013-07-24	2013-08-02	10,323	$6.07	$62.7K	786,917	SEC↗
ARRY ARRAY BIOPHARMA INC	A Award deriv	2013-03-28	2013-04-01	120,000	—	$0	120,000	SEC↗
ARRY ARRAY BIOPHARMA INC	A Award	2012-10-04	2012-10-05	22,718	—	$0	774,954	SEC↗
ARRY ARRAY BIOPHARMA INC	A Award deriv	2012-03-30	2012-04-03	90,000	—	$0	90,000	SEC↗